David Reimer

731 total citations
13 papers, 592 citations indexed

About

David Reimer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Reimer has authored 13 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Reimer's work include Inhalation and Respiratory Drug Delivery (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). David Reimer is often cited by papers focused on Inhalation and Respiratory Drug Delivery (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). David Reimer collaborates with scholars based in United States, Switzerland and Netherlands. David Reimer's co-authors include Tamara Minko, Olga B. Garbuzenko, Vitaly P. Pozharov, Kenneth R. Reuhl, Debra L. Laskin, Alexandre A. Vetcher, Viatcheslav A. Soldatenkov, Min Zhang, Maha Saad and Michael S. Leib and has published in prestigious journals such as Journal of Controlled Release, Pharmaceutical Research and Toxicology and Applied Pharmacology.

In The Last Decade

David Reimer

11 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Reimer United States 11 202 191 85 68 56 13 592
William G. Love United Kingdom 13 167 0.8× 110 0.6× 57 0.7× 21 0.3× 15 0.3× 32 468
Ching‐Ju Shen Taiwan 14 328 1.6× 41 0.2× 31 0.4× 22 0.3× 42 0.8× 38 770
Ralph Woessner Switzerland 18 433 2.1× 171 0.9× 39 0.5× 35 0.5× 20 0.4× 62 958
Olga Cañadas Spain 18 244 1.2× 468 2.5× 100 1.2× 10 0.1× 71 1.3× 28 938
Vincent V. Suzara United States 6 195 1.0× 82 0.4× 22 0.3× 24 0.4× 15 0.3× 8 561
Marius Hittinger Germany 14 203 1.0× 266 1.4× 69 0.8× 15 0.2× 215 3.8× 26 664
Jacob Witten United States 13 455 2.3× 132 0.7× 71 0.8× 8 0.1× 132 2.4× 20 774
N.C. Phillips Canada 15 368 1.8× 85 0.4× 87 1.0× 23 0.3× 141 2.5× 31 797
Noemi Poerio Italy 13 219 1.1× 44 0.2× 66 0.8× 13 0.2× 57 1.0× 22 527

Countries citing papers authored by David Reimer

Since Specialization
Citations

This map shows the geographic impact of David Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reimer more than expected).

Fields of papers citing papers by David Reimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reimer. The network helps show where David Reimer may publish in the future.

Co-authorship network of co-authors of David Reimer

This figure shows the co-authorship network connecting the top 25 collaborators of David Reimer. A scholar is included among the top collaborators of David Reimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Reimer. David Reimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Reimer, David, et al.. (2023). Effects of Different Grades of Carbon Dioxide on Euthanasia of Mice (Mus musculus). Journal of the American Association for Laboratory Animal Science. 62(5). 430–437.
3.
Garbuzenko, Olga B., et al.. (2017). Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s). Nanomedicine Nanotechnology Biology and Medicine. 13(6). 1983–1992. 55 indexed citations
4.
Sahota, Amrik, Kathleen M. Capaccione, Min Yang, et al.. (2014). Novel Cystine Ester Mimics for the Treatment of Cystinuria-induced Urolithiasis in a Knockout Mouse Model. Urology. 84(5). 1249.e9–1249.e15. 20 indexed citations
5.
Garbuzenko, Olga B., et al.. (2012). Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. European Journal of Pharmaceutics and Biopharmaceutics. 84(2). 335–344. 68 indexed citations
6.
Kutscher, Hilliard L., Piyun Chao, Manjeet Deshmukh, et al.. (2010). Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. Journal of Controlled Release. 143(1). 31–37. 92 indexed citations
7.
Sunil, Vasanthi R., Jianliang Shen, David Reimer, et al.. (2010). Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard. Toxicology and Applied Pharmacology. 250(1). 10–18. 51 indexed citations
8.
Reimer, David, et al.. (2010). Characterization and biological activity of relaxin in porcine milk. Reproduction. 141(3). 373–380. 24 indexed citations
9.
Sahota, Amrik, Catherine Schuler, Min Yang, et al.. (2009). Bladder outlet obstruction in male cystinuria mice. International Urology and Nephrology. 42(1). 57–63. 14 indexed citations
10.
Garbuzenko, Olga B., Maha Saad, Min Zhang, et al.. (2008). Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug. Pharmaceutical Research. 26(2). 382–394. 132 indexed citations
11.
Johnston, Spencer A., et al.. (1999). The Gastroduodenal Effects of Buffered Aspirin, Carprofen, and Etodolac in Healthy Dogs. Journal of Veterinary Internal Medicine. 13(5). 472–477. 66 indexed citations
12.
Johnston, Spencer A., et al.. (1999). The Gastroduodenal Effects of Buffered Aspirin, Carprofen, and Etodolac in Healthy Dogs. Journal of Veterinary Internal Medicine. 13(5). 472–472. 16 indexed citations
13.
Reimer, David, Joachim Frey, Ruud Jansen, Hugo P. Veit, & Thomas J. Inzana. (1995). Molecular investigation of the role of Apxl and Apxll in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microbial Pathogenesis. 18(3). 197–209. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William G. Love Breakdown of academic impact, for papers by Ching‐Ju Shen Breakdown of academic impact, for papers by Ralph Woessner Breakdown of academic impact, for papers by Olga Cañadas Breakdown of academic impact, for papers by Vincent V. Suzara Breakdown of academic impact, for papers by Marius Hittinger Breakdown of academic impact, for papers by Jacob Witten Breakdown of academic impact, for papers by N.C. Phillips Breakdown of academic impact, for papers by Noemi Poerio
Rankless by CCL
2026